2023
Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set.
Seminars in arthritis and rheumatism
PubMed • Publisher's siteResearch at a glance
Top areas of exploration
- Gout , 46 publications
- Gout Suppressants , 25 publications
- Uric Acid , 24 publications
- Chronic Disease , 14 publications
Research activity
My publications
Filter publications
76 publications
2022
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.
Current rheumatology reports
PubMed • Publisher's site2022
Gout management and outcomes during established COVID-19 pandemic in 2020-2021: a cross-sectional Internet survey.
Therapeutic advances in musculoskeletal disease
PubMed • Publisher's site2021
Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares.
Clinical and experimental rheumatology
PubMed • Publisher's site2021
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group.
Seminars in arthritis and rheumatism
PubMed • Publisher's site